Moneycontrol PRO

Beryl Drugs Standalone March 2022 Net Sales at Rs 3.47 crore, down 42.8% Y-o-Y

June 01, 2022 / 03:35 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Beryl Drugs are:

Net Sales at Rs 3.47 crore in March 2022 down 42.8% from Rs. 6.06 crore in March 2021.

Quarterly Net Loss at Rs. 0.47 crore in March 2022 down 504.78% from Rs. 0.12 crore in March 2021.

EBITDA stands negative at Rs. 0.29 crore in March 2022 down 216% from Rs. 0.25 crore in March 2021.

Beryl Drugs shares closed at 7.95 on May 31, 2022 (BSE) and has given -21.98% returns over the last 6 months and -19.62% over the last 12 months.

Close
Beryl Drugs
Standalone Quarterly Resultsin Rs. Cr.
Mar'22Dec'21Mar'21
Net Sales/Income from operations3.473.186.06
Other Operating Income------
Total Income From Operations3.473.186.06
EXPENDITURE
Consumption of Raw Materials2.791.712.47
Purchase of Traded Goods------
Increase/Decrease in Stocks-0.400.011.08
Power & Fuel------
Employees Cost0.290.390.33
Depreciation0.270.270.24
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses1.130.861.56
P/L Before Other Inc. , Int., Excpt. Items & Tax-0.61-0.070.40
Other Income0.050.04-0.39
P/L Before Int., Excpt. Items & Tax-0.56-0.030.01
Interest0.100.120.14
P/L Before Exceptional Items & Tax-0.66-0.14-0.14
Exceptional Items----0.45
P/L Before Tax-0.66-0.140.32
Tax-0.18-0.040.20
P/L After Tax from Ordinary Activities-0.47-0.100.12
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period-0.47-0.100.12
Equity Share Capital5.075.075.07
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS-0.94-0.180.23
Diluted EPS-0.94-0.180.23
EPS After Extra Ordinary
Basic EPS-0.94-0.180.23
Diluted EPS-0.94-0.180.23
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

first published: Jun 1, 2022 03:30 pm
Sections
ISO 27001 - BSI Assurance Mark